In Vitro and In Vivo Activities of Contezolid (MRX-I) against Mycobacterium tuberculosis
Author:
Affiliation:
1. Central New York Research Corporation, Syracuse, New York, USA
2. MicuRx Pharmaceuticals, Hayward, California, USA
3. Veterans Affairs Medical Center, Syracuse, New York, USA
Abstract
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Link
https://journals.asm.org/doi/pdf/10.1128/AAC.00493-18
Reference9 articles.
1. Oxazolidinones, a new class of synthetic antituberculosis agent in vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis
2. Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721
3. Identification of a Novel Oxazolidinone (U-100480) with Potent Antimycobacterial Activity
4. Activities of Several Novel Oxazolidinones against Mycobacterium tuberculosis in a Murine Model
5. Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identification and optimization of pyridine carboxamide-based scaffold as a drug lead for Mycobacterium tuberculosis;Antimicrobial Agents and Chemotherapy;2024-01-09
2. Contezolid can replace linezolid in a novel combination with bedaquiline and pretomanid in a murine model of tuberculosis;Antimicrobial Agents and Chemotherapy;2023-12-14
3. Tuberculosis patients with special clinical conditions treated with contezolid: three case reports and a literature review;Frontiers in Medicine;2023-12-14
4. Case report: Successful treatment with contezolid in a patient with tuberculous meningitis who was intolerant to linezolid;Frontiers in Medicine;2023-10-19
5. Clinical Utility of Contezolid-Containing Regimens in 25 Cases of Linezolid-Intolerable Tuberculosis Patients;Infection and Drug Resistance;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3